Wang Zheng, Zhang Qi-Feng, Guo Miao, Qi Xiao-Xia, Xing Xiao-Hui, Li Gang, Zhang Shuang-Long
Department of Critical Care Medicine, Peking University International Hospital, Beijing, China.
Front Cardiovasc Med. 2024 Apr 11;11:1370696. doi: 10.3389/fcvm.2024.1370696. eCollection 2024.
The presence of cerebral-cardiac syndrome, wherein brain diseases coincide with heart dysfunction, significantly impacts patient prognosis. In severe instances, circulatory failure may ensue, posing a life-threatening scenario necessitating immediate life support measures, particularly effective circulatory support methods. The application of extracorporeal membrane oxygenation (ECMO) is extensively employed as a valuable modality for delivering circulatory and respiratory support in the care of individuals experiencing life-threatening circulatory and respiratory failure. This approach facilitates a critical temporal window for subsequent interventions. Consequently, ECMO has emerged as a potentially effective life support modality for patients experiencing severe circulatory failure in the context of cerebral-cardiac syndrome. However, the existing literature on this field of study remains limited.
In this paper, we present a case study of a patient experiencing a critical cerebral-cardiac syndrome. The individual successfully underwent veno-arterial-ECMO (VA-ECMO) therapy, and the patient not only survived, but also received rehabilitation treatment, demonstrating its efficacy as a life support intervention.
VA-ECMO could potentially serve as an efficacious life support modality for individuals experiencing severe circulatory failure attributable to cerebral-cardiac syndrome.
脑心综合征(即脑部疾病与心脏功能障碍同时出现)的存在对患者预后有显著影响。在严重情况下,可能会出现循环衰竭,这是一种危及生命的情况,需要立即采取生命支持措施,特别是有效的循环支持方法。体外膜肺氧合(ECMO)的应用被广泛用作一种重要手段,为患有危及生命的循环和呼吸衰竭的个体提供循环和呼吸支持。这种方法为后续干预提供了关键的时间窗口。因此,ECMO已成为脑心综合征背景下严重循环衰竭患者潜在有效的生命支持方式。然而,该研究领域的现有文献仍然有限。
在本文中,我们展示了一例患有严重脑心综合征患者的病例研究。该患者成功接受了静脉-动脉体外膜肺氧合(VA-ECMO)治疗,不仅存活下来,还接受了康复治疗,证明了其作为生命支持干预措施的有效性。
VA-ECMO可能是脑心综合征所致严重循环衰竭患者有效的生命支持方式。